We selected six cases to capture three clinical subtypes of breast cancer: ER+HER2−, ER/PR/HER2− [triple-negative breast cancer (TNBC)], and HER2+ (Supplementary Fig. S6). Here, ERBB2 is linked to triple-negative breast carcinoma.